Oncopeptides AB (publ) (STO: ONCO)
Sweden
· Delayed Price · Currency is SEK 1.438
-0.012 (-0.83%)
Nov 19, 2024, 5:29 PM CET
Oncopeptides AB Revenue
Oncopeptides AB had revenue of 8.51M SEK in the quarter ending September 30, 2024, with 203.28% growth. This brings the company's revenue in the last twelve months to 27.07M, down -11.08% year-over-year. In the year 2023, Oncopeptides AB had annual revenue of 35.22M with 321.54% growth.
Revenue (ttm)
27.07M
Revenue Growth
-11.08%
P/S Ratio
7.48
Revenue / Employee
342.67K
Employees
57
Market Cap
320.20M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 18.12B |
Oncopeptides AB News
- 3 months ago - Oncopeptides AB (OSTO:ONCO) Q2 2024 Earnings Call Transcript Highlights: Revenue Surge and ... - GuruFocus
- 3 months ago - Q2 2024 Oncopeptides AB Earnings Call Transcript - GuruFocus